| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.7928 | 26 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.1165 | 14 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.2662 | 19 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.403 | 24 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.7893 | 40 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.8066 | 26 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.6069 | 30 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.3821 | 46 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.0576 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.8792 | 22 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.8775 | 41 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.5873 | 30 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.8753 | 31 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.7674 | 21 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.4012 | 24 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.2482 | 42 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.9307 | 45 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.7748 | 40 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.3626 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.4593 | 47 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.421 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.505 | 43 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.7596 | 36 |